​​August 11, 2017
LEVO THERAPEUTICS ANNOUNCES COMPLETION OF SERIES A FINANCING 



December 12, 2016
LEVO THERAPEUTICS' COLLABORATING INVESTIGATORS PUBLISH DISCOVERY OF NOVEL TARGET FOR PRADER-WILLI SYNDROME



October 27, 2016

LEVO THERAPEUTICS TO LICENSE EXCLUSIVE RIGHTS TO FERRING PHARMACEUTICALS' ORPHAN-DESIGNATED DRUG, CARBETOCIN, FOR THE TREATMENT OF PRADER-WILLI SYNDROME

​​​​​​​levo therapeutics

Follow Us


© 2016 | Levo Therapeutics, Inc.